US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MU $934.27 ▼-4.98% MSFT $530.14 ▼-0.16% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

Elevance Health, Inc. Common Stock (NY:ELV)

422.02 +7.61 (+1.84%)
Official Closing Price Updated: 7:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
News headline image
1 safe-and-steady stock with solid fundamentals and 2 we brush off
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. Choosing the... 
Via StockStory
News headline image
ELV Q3 deep dive: Carelon expansion and Medicaid margin actions underpin raised outlook
Health insurance provider Elevance Health (NYSE:ELV) reported Q3 2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at... 
Via StockStory
News headline image
Elevance: 3 Key Takeaways for Long-Term Investors ↗
Clinical efficiency gains and integrated pharmacy benefits are lengthening the runway for margin expansion beyond 2026. 
Via The Motley Fool
Topics Earnings
News headline image
Elevance (ELV) Q3 2026 Earnings Call Transcript ↗
CEO Boudreaux raised full-year guidance on Medicaid improvements and Carelon momentum. 
Via The Motley Fool
Topics Earnings
Elevance Health (NYSE:ELV) Shares Rise as Q3 Earnings Beat and Raised Outlook Offset Inline Revenue ↗
Via Chartmill
Topics Earnings
News headline image
What Elevance Health (ELV) Said on Its Q3 Earnings Call ↗
Elevance Health (NYSE:ELV) raised its 2026 earnings outlook after reporting third-quarter adjusted diluted earnings per share of $6.99, exceeding the company’s expectations as Medicaid, Medicare... 
Via MarketBeat
Topics ETFs Earnings
News headline image
Elevance Health Names Jeff Park President of Carelon
From Elevance Health, Inc.
Via Business Wire
News headline image
Elevance Health (NYSE:ELV) Reports Bullish Q3 2026
Health insurance provider Elevance Health (NYSE:ELV) reported revenue ahead of Wall Street’s expectations in Q3 2026, but sales were flat year on year at $50... 
Via StockStory
News headline image
Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
From Elevance Health, Inc.
Via Business Wire
News headline image
Earnings To Watch: Elevance Health (ELV) Reports Q3 Results Tomorrow
Health insurance provider Elevance Health (NYSE:ELV) will be reporting results this Wednesday before market hours. Here’s what investors should know. Elevanc... 
Via StockStory
Topics Artificial Intelligence
AINewsBreaks – ECGI Holdings Inc. (OTC: ECGI) Highlights Avanta Acquisition and Growing Opportunities in $5.3 Trillion U.S. Healthcare Market
Via Investor Brand Network
Topics Artificial Intelligence
The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
Via Investor Brand Network
Topics Artificial Intelligence
Which S&P500 stocks are moving before the opening bell on Friday? ↗
Via Chartmill
News headline image
2 Stocks to Buy Hand Over Fist in October ↗
Nutex Health and Elevance Health may be underpriced, despite their share growth this year. 
Via The Motley Fool
News headline image
The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
From AINewsWire
Via GlobeNewswire
News headline image
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
From Elevance Health, Inc.
Via Business Wire
News headline image
Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
From Elevance Health, Inc.
Via Business Wire
News headline image
2 Surging Stocks on Our Watchlist and 1 We Brush Off
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
News headline image
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financia... 
Via StockStory
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
2 Reasons to Watch ELV and 1 to Stay Cautious
What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per sha... 
Via StockStory
Topics Supply Chain
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
2 Large-Cap Stocks with Promising Prospects and 1 Facing Headwinds
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m... 
Via StockStory
News headline image
Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
From Elevance Health, Inc.
Via Business Wire
News headline image
UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal ↗
UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction. 
Via MarketBeat
News headline image
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now? ↗
Peru's $366,050 purchase expands his direct stake to 10,908 shares, now valued at $4.03 million following the stock's 22% one-year gain. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Value Stock to Consider Right Now and 2 Facing Headwinds
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook? ↗
Boudreaux's stake now totals ~172,000 directly held shares worth $63.51 million, as Elevance maintains an $80 billion market cap and $5.0 billion in trailing net income. 
Via The Motley Fool
Topics Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >